What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Chemotherapy
His main research concerns Internal medicine, Pharmacokinetics, Pharmacology, Chemotherapy and Gastroenterology.
Frank M. Balis has researched Internal medicine in several fields, including Immunology, Endocrinology, Surgery and Oncology.
Frank M. Balis has included themes like Carboplatin, Cancer, Primitive neuroectodermal tumor and Neurocytoma in his Oncology study.
Frank M. Balis combines subjects such as Oral administration, Anesthesia, Cerebrospinal fluid and Drug with his study of Pharmacokinetics.
His Pharmacology study combines topics from a wide range of disciplines, such as P-glycoprotein, Tariquidar, Methotrexate and Clinical trial.
His work carried out in the field of Gastroenterology brings together such families of science as Discontinuation, Refractory, Salvage therapy, Antifolate and Nausea.
His most cited work include:
- Pteridine nucleotide analogs as fluorescent dna probes (605 citations)
- Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study (440 citations)
- Effect of Continuous Intravenous Infusion of Zidovudine (AZT) in Children with Symptomatic HIV Infection (386 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Pharmacokinetics, Pharmacology, Internal medicine, Chemotherapy and Toxicity.
His work deals with themes such as Oral administration, Anesthesia, Cerebrospinal fluid, Refractory and Blood plasma, which intersect with Pharmacokinetics.
His research integrates issues of Metabolite and Methotrexate in his study of Pharmacology.
His Internal medicine research incorporates themes from Gastroenterology, Endocrinology, Surgery and Oncology.
The various areas that Frank M. Balis examines in his Chemotherapy study include Mercaptopurine and Urology.
His studies deal with areas such as Immunology, Fluorouracil and Pharmacodynamics as well as Toxicity.
He most often published in these fields:
- Pharmacokinetics (50.15%)
- Pharmacology (44.41%)
- Internal medicine (40.48%)
What were the highlights of his more recent work (between 2009-2021)?
- Internal medicine (40.48%)
- Oncology (15.71%)
- Pharmacokinetics (50.15%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Oncology, Pharmacokinetics, Pharmacology and Cancer.
His studies in Internal medicine integrate themes in fields like Gastroenterology, Endocrinology and Neuroblastoma.
The Oncology study combines topics in areas such as Clinical trial, Tipifarnib, Neurofibromatosis, Tumor progression and Rash.
His Pharmacokinetics study combines topics in areas such as Leukemia, Refractory, Sorafenib and Dosing.
His study in Pharmacology is interdisciplinary in nature, drawing from both Cerebrospinal fluid, Cisplatin, Pathogenesis, Docetaxel and Tariquidar.
His Cancer research focuses on subjects like Lung cancer, which are linked to Large cell, Anaplastic large-cell lymphoma and Neutropenia.
Between 2009 and 2021, his most popular works were:
- Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study (440 citations)
- A Pharmacodynamic Study of Docetaxel in Combination with the P-glycoprotein Antagonist Tariquidar (XR9576) in Patients with Lung, Ovarian, and Cervical Cancer (112 citations)
- Vandetanib in Children and Adolescents with Multiple Endocrine Neoplasia Type 2B Associated Medullary Thyroid Carcinoma (99 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Chemotherapy
Frank M. Balis mainly focuses on Internal medicine, Oncology, Pharmacokinetics, Cancer and Gastroenterology.
While the research belongs to areas of Internal medicine, Frank M. Balis spends his time largely on the problem of Surgery, intersecting his research to questions surrounding Cohort.
His research in Oncology intersects with topics in Phases of clinical research, Neutropenia, Neurofibromatosis, Anaplastic large-cell lymphoma and Rash.
His Pharmacokinetics research entails a greater understanding of Pharmacology.
His Cancer research includes elements of Lung cancer, Clinical trial and Clinical psychology.
He interconnects Nausea and Vomiting in the investigation of issues within Gastroenterology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
